查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1732851

放射治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、最終用戶、地區和競爭細分，2020-2030 年

Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type, By Application, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球放射治療市場價值為 65.4 億美元，預計到 2030 年將達到 106.8 億美元，預測期內複合年成長率為 8.52%。放射療法仍然是癌症治療的基石，利用電離輻射消除或縮小癌細胞並控制病情進展。隨著全球癌症發病率的不斷上升以及對非侵入性治療方案的日益關注，放射治療正在經歷強勁成長。 IMRT、SBRT 和質子治療等先進技術的採用正在改變治療格局，提供更高的精確度和更少的副作用。此外，人工智慧、即時成像和放射外科技術的整合正在提高治療效果和操作效率。全球醫療保健生態系統對有效腫瘤治療的重視，加上對個人化和針對性治療的需求不斷成長，繼續推動放射治療市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 65.4億美元
2030年市場規模 106.8億美元
2025-2030 年複合年成長率 8.52%
成長最快的領域 醫院
最大的市場 北美洲

關鍵市場促進因素

技術進步

主要市場挑戰

成本和可達性障礙

主要市場趨勢

先進的放射治療技術

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球放射治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（體外放射治療、內照射放射治療、全身放射治療）
    • 依應用（皮膚和唇癌、乳癌、攝護腺癌、子宮頸癌、肺癌、其他）
    • 按最終使用者（醫院、研究機構、門診和放射治療中心）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美放射治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲放射治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太放射治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲放射治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲放射治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球放射治療市場：SWOT 分析

第 14 章：競爭格局

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16287

The Global Radiotherapy Market was valued at USD 6.54 Billion in 2024 and is projected to reach USD 10.68 Billion by 2030, expanding at a CAGR of 8.52% during the forecast period. Radiotherapy remains a cornerstone in cancer treatment, employing ionizing radiation to eliminate or shrink cancer cells and manage disease progression. With the increasing global incidence of cancer and the rising focus on non-invasive therapeutic solutions, radiotherapy is witnessing robust growth. The adoption of advanced technologies like IMRT, SBRT, and proton therapy is transforming the treatment landscape, offering higher precision and fewer side effects. Additionally, the integration of AI, real-time imaging, and radiosurgery techniques is enhancing treatment outcomes and operational efficiency. The global healthcare ecosystem's emphasis on effective oncology care, coupled with the growing demand for personalized and targeted treatments, continues to drive the expansion of the radiotherapy market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.54 Billion
Market Size 2030USD 10.68 Billion
CAGR 2025-20308.52%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Ongoing technological innovations have significantly fueled the growth of the Global Radiotherapy Market. The emergence of advanced techniques like Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and Proton Therapy has revolutionized cancer care by enabling highly accurate targeting of tumors while preserving surrounding healthy tissue. This precision leads to improved outcomes and fewer adverse effects, making radiotherapy a preferred choice. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly integrated into treatment planning, enhancing dose optimization and patient response prediction. Image-Guided Radiotherapy (IGRT) further ensures real-time monitoring during treatment, improving targeting accuracy. Additionally, the development of Radiosurgery and Stereotactic Radiosurgery (SRS) allows for high-dose, single-session treatments for small tumors, offering patients convenience and reduced treatment durations.

Key Market Challenges

Cost and Accessibility Barriers

One of the major barriers in the radiotherapy market is the high cost of implementation. Advanced radiotherapy systems, such as linear accelerators and proton therapy units, demand substantial capital investment, which can be a major hurdle for healthcare providers, especially in under-resourced regions. Beyond the purchase, ongoing maintenance, staff training, and operational expenses place additional financial pressure on facilities. Disparities in access are also a concern, with rural and low-income areas often lacking sufficient infrastructure for radiotherapy services. These challenges contribute to unequal access to advanced cancer care, limiting the market's reach and slowing the pace of widespread adoption despite growing demand.

Key Market Trends

Advanced Radiation Delivery Techniques

The evolution of advanced radiation delivery methods is reshaping the radiotherapy landscape. Techniques such as IMRT allow for modulation of radiation intensity to different areas of the tumor, minimizing impact on nearby healthy tissues and improving treatment precision. Proton therapy offers an even more targeted approach, as protons release energy directly at the tumor site, reducing collateral damage. Additionally, hypofractionation-delivering higher doses over fewer sessions-is gaining popularity for its convenience and efficiency. Stereotactic Radiosurgery (SRS), a form of hypofractionation, is increasingly used for treating small brain and body tumors. These innovations align with the growing demand for personalized treatment strategies that prioritize both efficacy and patient quality of life.

Key Market Players

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

Report Scope:

In this report, the Global Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiotherapy Market, By Type:

  • External Beam Radiation Therapy
  • Internal Radiation Therapy
  • Systemic Radiation Therapy

Radiotherapy Market, By Application:

  • Skin & Lip Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Radiotherapy Market, By End-User:

  • Hospitals
  • Research Institutes
  • Ambulatory and Radiotherapy Centers

Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiotherapy Market.

Available Customizations:

Global Radiotherapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy)
    • 5.2.2. By Application (Skin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Others)
    • 5.2.3. By End-User (Hospitals, Research Institutes, Ambulatory and Radiotherapy Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. South America Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Radiotherapy Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Canon Medical Systems Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. GE Healthcare
  • 14.3. Elekta
  • 14.4. ViewRay Technologies, Inc.
  • 14.5. Mevion Medical Systems
  • 14.6. Eckert & Ziegler (BEBIG Medical)
  • 14.7. Siemens Healthineers AG
  • 14.8. Accuray Incorporated
  • 14.9. Isoray Inc.
  • 14.10. Hitachi, Ltd.
  • 14.11. ALCEN (PMB)

15. Strategic Recommendations

16. About Us & Disclaimer